Why the study?
Does eprosartan have clinically significant pharmacokinetic or pharmacodynamic interactions with commonly prescribed drugs?
Population
Subjects in clinical pharmacology studies
Design
Review
Authors
Loading...
Supports coadministration without adjustment in reviewed data; leaves open prospective validation in broader populations.
Does eprosartan have clinically significant pharmacokinetic or pharmacodynamic interactions with commonly prescribed drugs?
Eprosartan can be safely coadministered with digoxin, HCTZ, warfarin, glyburide, ranitidine, fluconazole, and ketoconazole without requiring dose adjustments.
Blum et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: